The launch of the Wegovy pill is being hailed as a turning point in obesity treatment, offering the first tablet version of a drug that has already reshaped the global weight-loss market. Approved this week by the Food and Drug Administration, the daily pill form of Wegovy replaces weekly injections with a simpler option that could widen appeal. Yet as prescriptions prepare to roll out, questions around cost and access are quickly emerging as central to whether the breakthrough translates into real-world change.
